UMike
Klutzing in Thai
- Joined
- 16 January 2007
- Posts
- 1,436
- Reactions
- 1,755
Well something happened at the close of trade today??????It's taking off a bit early...leakage of results?
Well something happened at the close of trade today??????It's taking off a bit early...leakage of results?
Entering the ASX/200 should be a moment of celebration for any biotech start-up. For Silvio Itescu, the multimillionaire founder and chief executive of stem cell group Mesoblast, it should be an even-greater triumph after a fourfold surge in the stock price spurred by an announcement that the company was assessing one of its drug candidates as a treatment for COVID-19 patients. On June 12, Mesoblast re-entered the ASX/200 as other healthcare companies Estia Health and Mayne Pharma dropped out.
https://www.afr.com/companies/healthcare-an...20200611-p551m3But it's been a roller-coaster ride and Itescu is still fending off critics. They say he is yet to prove the company's worth at over $2.3 billion, and note the regenerative medicine group is yet to produce a major commercial product despite raising over $1 billion in fresh equity since listing on the ASX in 2004 at just 50¢ per share. Long-time backers .... say Mesoblast is on the cusp of the next frontier in medicine. .....But critics ask why, if its prospects really are so good, some voracious pharma giant hasn't bought Mesoblast out or partnered with it after the better part of two decades plying its trade?....
Despite the big name support, the market is still split. Several analysts and fund managers say they lost interest after it failed to deliver on its "big promises" for many years.
"They have been just around the corner (from the next big breakthrough) for some time," says a portfolio manager. "Investors in this space do need to be patient. But good drugs don't tend to jump from indication to indication. I think Mesoblast started off in arthritis and now they're looking at COVID-19. They must've have tried at least ten indications.".....
Was kicking myself a week or so ago for not getting back in at the low $4s as it got close to the high $5sGot out a couple of days ago.
Looking forward to getting back in.
Down 10%. Gambling really isn't it.
Yes I was congratulating myself, up heaps then right back down to where it was in one day. Too many jumpy traders. I am trying to ignore the gyrations.Was kicking myself a week or so ago for not getting back in at the low $4s as it got close to the high $5s
Down over 25% today. A top 200 Company. Strange times.
Its always going to be a long haul when dealing with the FDA.Big drop today: closed at $3.36 (yesterday's close $4.87)
There seems to be much divided opinion about what the US regulators are actually going to grill Mesoblast about.
https://www.businessnewsaus.com.au/...ent-for-bone-marrow-transplant-condition.html
At best it's a show - us - what - you - got, so - we - can - tick - it - off
at worst it's a not - good - enough, - go - back - and - do - it - again.
Market dump on open, before today's clarification announcement from MSB:
https://www.asx.com.au/asxpdf/20200811/pdf/44ldcp6hdr4tt4.pdf
Hmm, big dump before ann? Still a couple days ahead of next regulators meeting?
Now isn't that interesting?
Could it be insiders know the grilling will be hot?
Or just scaredy-cats spooked by each other?
Discl: Don't hold at present.
Discl: and that's only because Monday's price hit my happy-point, and I sold ($4.66)
Whew!
So expect up the roof today?Passed the FDA ODAC. Vote was 8-2 in favour according to the article but have seen reported on HC that it was actually 9-1 as someone messed their vote up
https://www.smh.com.au/business/com...gets-us-tick-of-approval-20200813-p55liw.html
So expect up the roof today?
And what is up the roof after this week fall?
Yes i put a buy on open but did not want to go silly.this is not tesla yetI guess so, maybe on the chimney even, straight to $5 on open.
Still has to get final FDA approval but from what I gather the FDA has never knocked back anything voted for by ODAC. Not many Stem Cell therapies seem to have been approved by the FDA so if it passes could be good news for other MSB Phase 3 Trials.
https://www.asx.com.au/asxpdf/20200814/pdf/44lhlqglc3y569.pdfI guess so, maybe on the chimney even, straight to $5 on open.
Still has to get final FDA approval but from what I gather the FDA has never knocked back anything voted for by ODAC. Not many Stem Cell therapies seem to have been approved by the FDA so if it passes could be good news for other MSB Phase 3 Trials.
https://www.asx.com.au/asxpdf/20200814/pdf/44lhlqglc3y569.pdf
@wabullfrog You were very close to expectation on going through roof . It went up by 40%. More analysis and buying would consolidated the price I believe. Just bought couple of days back and not complaining some astute gamble .
No BS, it was a gamble and did not put money excessively either thinking the result could have gone south.
View attachment 107554
And i sold at 3.8 as per my system..can not win every day@Miner I did similar. Wednesday buy, small parcel, near the bottom.
I am trying to ignore the gyrations.
To me it would be reward for a long held hope!and is ready for the next leap forward, hopefully to $8.
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.